151 related articles for article (PubMed ID: 12841940)
1. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
Matzno S; Tazuya-Murayama K; Tanaka H; Yasuda S; Mishima M; Uchida T; Nakabayashi T; Matsuyama K
J Pharm Pharmacol; 2003 Jun; 55(6):795-802. PubMed ID: 12841940
[TBL] [Abstract][Full Text] [Related]
2. Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.
Nishiguchi T; Akiyoshi T; Anami S; Nakabayashi T; Matsuyama K; Matzno S
J Pharm Pharmacol; 2009 Jun; 61(6):781-8. PubMed ID: 19505369
[TBL] [Abstract][Full Text] [Related]
3. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
[TBL] [Abstract][Full Text] [Related]
4. Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein.
Matzno S; Yasuda S; Juman S; Yamamoto Y; Nagareya-Ishida N; Tazuya-Murayama K; Nakabayashi T; Matsuyama K
J Pharm Pharmacol; 2005 Nov; 57(11):1475-84. PubMed ID: 16259781
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with statins and bezafibrate induces myotoxicity via inhibition of geranylgeranyl pyrophosphate biosynthesis and Rho activation in L6 myoblasts and myotube cells.
Tsubaki M; Takeda T; Mastuda T; Kimura A; Yanae M; Maeda A; Hoshida T; Tanabe K; Nishida S
J Physiol Pharmacol; 2022 Feb; 73(1):. PubMed ID: 35793766
[TBL] [Abstract][Full Text] [Related]
6. [Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].
Sirvent AE; Cabezuelo JB; Enríquez R; Amorós F; González C; Reyes A
Nefrologia; 2001; 21(5):497-500. PubMed ID: 11795020
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric evaluation of synergistic pro-apoptotic effects of statins and clofibrates in IM-9 human lymphoblasts.
Tomiyama N; Yasuda N; Iwano C; Matzno S; Matsuyama K
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):876-80. PubMed ID: 17645633
[TBL] [Abstract][Full Text] [Related]
8. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
Jones PH; Davidson MH
Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
[TBL] [Abstract][Full Text] [Related]
9. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
Jamal SM; Eisenberg MJ; Christopoulos S
Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
[TBL] [Abstract][Full Text] [Related]
10. [Antilipemic therapy and rhabdomyolysis].
Paragh G; Balogh Z; Romics L
Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
12. [Rhabdomyolysis and acute renal failure secondary to statins].
Borrego FJ; Liébana A; Borrego J; Pérez del Barrio P; Gil JM; García Cortés MJ; Sánchez Perales C; Serrano P; Pérez Bañasco V
Nefrologia; 2001; 21(3):309-13. PubMed ID: 11471312
[TBL] [Abstract][Full Text] [Related]
13. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
Kind AH; Zakowski LJ; McBride PE
WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
Kamaliah MD; Sanjay LD
Singapore Med J; 2001 Aug; 42(8):368-72. PubMed ID: 11764054
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyolysis in association with simvastatin and amiodarone.
Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
[TBL] [Abstract][Full Text] [Related]
16. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE; Sowell MO; Stender M; Qizilbash N
Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of bicarbonate on cerivastatin-induced apoptosis.
Kobayashi M; Kaido F; Kagawa T; Itagaki S; Hirano T; Iseki K
Int J Pharm; 2007 Aug; 341(1-2):181-8. PubMed ID: 17553641
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of apoptosis and necrosis induced by statins using fluorescence-enhanced flow cytometry.
Yasuda N; Matzno S; Iwano C; Nishikata M; Matsuyama K
J Pharm Biomed Anal; 2005 Sep; 39(3-4):712-7. PubMed ID: 15927433
[TBL] [Abstract][Full Text] [Related]
19. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
[TBL] [Abstract][Full Text] [Related]
20. [Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States].
Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):41-5. PubMed ID: 16541751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]